Todd Harris
CIK 1711463 · President and CEO · last filed 2026-09-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TYRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 140
WESTLAKE VILLAGE, CA 91362
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | President and CEO | 1,438,495 | $21.09 | $30.34M | -$8.12M | 27 | 2026-09-17 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Head of Corporate Development | 570,991 | — | — | -$1.22M | 10 | 2019-06-03 |
Recent Filings · Page 3 of 5
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-26 | TYRA | Sell (S) | −24,190 | -$411.5K | EDGAR |
| 2023-06-21 | TYRA | Sell (S) | −75,810 | -$1.30M | EDGAR |
| 2023-06-16 | TYRA | Notice (144) | −100,000 | -$1.60M | EDGAR |
| 2023-06-15 | TYRA | Mixed | — | -$286.3K | EDGAR |
| 2023-04-05 | TYRA | Mixed | — | -$27.8K | EDGAR |
| 2023-03-31 | TYRA | Mixed | — | -$59.8K | EDGAR |
| 2023-03-28 | TYRA | Mixed | — | -$81.3K | EDGAR |
| 2023-03-23 | TYRA | Mixed | — | -$264.5K | EDGAR |
| 2023-03-17 | TYRA | Grant (A) | +1,808 | $11.9K | EDGAR |
| 2022-09-08 | TYRA | Grant (A) | +3,125 | $26.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.